CytRx CEO Steven Kriegsman is scheduled to present at the Roth Capital Partners’ annual growth stock conference on Feb. 19, 2004, the company said this week.
Kriegsman is expected to highlight CytRx’s recent collaborations in the field of RNAi and small-molecule drug development, and also give an overview of the company’s other drug development programs.
The Roth meeting is scheduled for Feb. 16-19 at the St. Regis Monarch Beach Resort and Spa in Dana Point, Calif.